Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 μ (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 kg (Expand Search)
5 nm » 5 mm (Expand Search), 5 cm (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 μ (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 kg (Expand Search)
5 nm » 5 mm (Expand Search), 5 cm (Expand Search)
-
1
-
2
Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades
Published 2022“…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. …”
-
3
Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades
Published 2022“…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. …”
-
4
ETX treatment causes a down regulation in claudin-5 staining.
Published 2019“…(C) Down regulation of claudin-5 was also confirmed <i>in-vitro</i>. Primary mouse BEC were treated with or without 50nM ETX for two hours and then stained for claudin-5. …”
-
5
-
6
Fig 2 -
Published 2021“…Myoblasts were differentiated for 72 h and treated with 10 μM Dex, or 10 μM Dex plus 300 nM or 600 nM Ni or 50 ng/ml bovine insulin for 24 h. …”
-
7
Fig 6 -
Published 2021“…F) Representative DIC images of untreated C2C12 myotubes or myotubes treated with 100 ng/mL TNF-α and 150 nM, or 1.5 μM, Ni for 24 h. …”
-
8
Fig 4 -
Published 2021“…<p>A) qPCR analysis of <i>Pax7</i>, <i>Myf5</i>, <i>Myod</i>, <i>Myog</i> and <i>Myh2</i> expression in differentiating C2C12 myoblasts treated with 150 nM, 300 nM or 600 nM Ni for 24 h. * = <i>p</i><0.05, ** = <i>p</i><0.01 and *** = <i>p</i><0.001 indicate significantly increased or decreased expression compared to untreated myoblasts. …”
-
9
Purification and characterization of the deletion mutants.
Published 2021“…<b>(C)</b> EMSA gels using no RNA, 10 nM 0–5 kb viral RNA, or 50 ng/μL polyC RNA and decreasing concentration of the ΔR2 mutant. …”
-
10
Gel filtration and EMSA analysis of the WT N protein purified from HEK293S GNTI- cells.
Published 2021“…The yellow arrowhead shows the expected molecular weight of full-length N protein. <b>(F)</b> EMSA using no RNA, 10 nM 0–5 kb viral RNA, and 50 ng/μL polyC RNA and decreasing concentration of N protein. …”
-
11